SENSITIVE CAPILLARY GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC METHOD FOR THE THERAPEUTIC DRUG-MONITORING OF VALPROIC ACID AND 7 OF ITS METABOLITES IN HUMAN SERUM - APPLICATION OF THE ASSAY FOR A GROUP OF PEDIATRIC EPILEPTICS

被引:22
作者
DARIUS, J
MEYER, FP
机构
[1] Department of Clinical Pharmacology, University Hospital, Otto von Guericke University, D-39120 Magdeburg
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1994年 / 656卷 / 02期
关键词
D O I
10.1016/0378-4347(94)00129-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive capillary gas chromatographic-mass spectrometric method for the determination of valproic acid and 7 of its metabolites is described. It is based on the selected-ion monitoring of the tert.-butyldimethylsilyl derivatives using N-(tert.-butyldimethylsilyl)-N-methyl-trifluoracetamid (MTBSTFA) as the derivatization reagent. The limits of detection for valproic acid and its metabolites are in the low ng/ml-range, except for the 4-hydroxy metabolite with a limit of detection of 100 ng/ml. The method has been tested against an established GC method for valproic acid. The assay has been used for therapeutic drug monitoring in epileptic pediatric patients. The concentrations of the omega- and omega 1-oxidation metabolites in a group of patients receiving additional antiepileptic drugs were found to be significantly enhanced compared to the levels found in a monotherapy group.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 26 条
  • [1] CAPILLARY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY OF VALPROIC ACID METABOLITES IN SERUM AND URINE USING TERT-BUTYLDIMETHYLSILYL DERIVATIVES
    ABBOTT, FS
    KASSAM, J
    ACHEAMPONG, A
    FERGUSON, S
    PANESAR, S
    BURTON, R
    FARRELL, K
    ORR, J
    [J]. JOURNAL OF CHROMATOGRAPHY, 1986, 375 (02): : 285 - 298
  • [2] IDENTIFICATION OF VALPROIC ACID METABOLITES IN HUMAN-SERUM AND URINE USING HEXADEUTERATED VALPROIC ACID AND GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ANALYSIS
    ACHEAMPONG, A
    ABBOTT, F
    BURTON, R
    [J]. BIOMEDICAL MASS SPECTROMETRY, 1983, 10 (11): : 586 - 595
  • [3] BOURGEOIS BFD, 1989, ANTIEPILEPTIC DRUGS, P633
  • [4] BROWN R, 1989, J CLIN PSYCHIAT, V50, P13
  • [5] QUANTITATIVE-DETERMINATION OF VALPROIC ACID AND 14 METABOLITES IN SERUM AND URINE BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY
    FISHER, E
    WITTFOHT, W
    NAU, H
    [J]. BIOMEDICAL CHROMATOGRAPHY, 1992, 6 (01) : 24 - 29
  • [6] METABOLIC PROFILING OF VALPROIC ACID IN PATIENTS USING NEGATIVE-ION CHEMICAL IONIZATION GAS-CHROMATOGRAPHY MASS-SPECTROMETRY
    KASSAHUN, K
    FARRELL, K
    ZHENG, JJ
    ABBOTT, F
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 527 (02): : 327 - 341
  • [7] THE HEPATOTOXICITY OF VALPROIC ACID AND ITS METABOLITES IN RATS .1. TOXICOLOGIC, BIOCHEMICAL AND HISTOPATHOLOGIC STUDIES
    KESTERSON, JW
    GRANNEMAN, GR
    MACHINIST, JM
    [J]. HEPATOLOGY, 1984, 4 (06) : 1143 - 1152
  • [8] ASSOCIATIONS BETWEEN RISK-FACTORS FOR VALPROATE HEPATOTOXICITY AND ALTERED VALPROATE METABOLISM
    KONDO, T
    KANEKO, S
    OTANI, K
    ISHIDA, M
    HIRANO, T
    FUKUSHIMA, Y
    MURANAKA, H
    KOIDE, N
    YOKOYAMA, M
    [J]. EPILEPSIA, 1992, 33 (01) : 172 - 177
  • [9] KUHARA T, 1983, CLIN CHIM ACTA, V133, P133
  • [10] ALTERED METABOLIC PROFILES OF VALPROIC ACID IN A PATIENT WITH REYES-SYNDROME
    KUHARA, T
    INOUE, Y
    MATSUMOTO, M
    SHINKA, T
    MATSUMOTO, I
    KITAMURA, K
    FUJII, H
    SAKURA, N
    [J]. CLINICA CHIMICA ACTA, 1985, 145 (02) : 135 - 142